Clicky

Nanobiotix S.A(NANO) News

Date Title
May 6 Nanobiotix presents outcomes from trial of JNJ-1900 for pancreatic cancer
May 5 Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
Apr 4 Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Apr 2 NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
Mar 31 NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
Mar 27 Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Feb 14 Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In?
Feb 12 Voting Rights and Shares Capital of the Company